.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 8,555,878

« Back to Dashboard

Details for Patent: 8,555,878

Title:Nasal delivery device
Abstract: A delivery device (20, 22) for and a method of delivering a substance to the nasal airway (1) of a subject, in particular the posterior region of the nasal airway, the delivery device comprising: a closure unit for causing the closure of the oropharyngeal velum of the subject; and a delivery unit for delivering a gas flow entraining a substance to one of the nostrils of the subject at such a driving pressure as to flow around the posterior margin of the nasal septum and out of the other nostril of the subject, wherein the delivery unit comprises a nosepiece (30, 40, 58, 82, 102, 132) which includes an outlet through which the gas flow is in use delivered to the one nostril and a sealing member for sealing the one nostril to the outlet such as in use to prevent the escape of the gas flow through the one nostril.
Inventor(s): Djupesland; Per Gisle (Oslo, NO)
Assignee: OptiNose AS (Oslo, NO)
Filing Date:Jun 02, 2006
Application Number:11/445,994
Claims:1. A manually-actuated device for delivering a substance to the nasal airway of a subject, comprising: a flow resistor; and a nosepiece shaped and sized for insertion into a nostril of the subject comprising an outlet through which a substance may be delivered into the nasal airway of the subject, and a sealing member configured to seal the one nostril of the subject to the outlet, the sealing member having a first, distal end and a second, proximal end and being enlarged towards the proximal end to cause an anterior region of the nasal cavity into which the nosepiece is inserted to be enlarged; and a substance supply unit in fluid communication with the outlet of the nosepiece and including a dispensing unit which is manually actuated to dispense a metered dose of substance into an exhalation air flow, wherein the exhalation air flow has a flow rate of at least 10 liters per minute; wherein the device is configured to create a positive pressure differential between the oral cavity of the subject and the nasal airway of the subject when the subject exhales against the flow resistor, thereby indirectly achieving closure of the oropharyngeal velum of the subject.

2. The device of claim 1, wherein the flow resistor is operably connected to a tubular section configured to be held between the lips of the subject.

3. The device of claim 1, wherein the flow resistor is operably connected to a mouthpiece.

4. The device of claim 1, wherein the flow resistor is fluidly connected to the nosepiece and located upstream of the substance supply unit.

5. The device of claim 1, wherein the nosepiece is formed of a resilient material.

6. The device of claim 1, wherein the nosepiece is configured to extend into a nasal cavity of the subject so as to expand the valve region of the nasal cavity of the subject.

7. The device of claim 1, further comprising: a positive pressure indicator or a flow rate indicator.

8. The device of claim 1, wherein the gas flow entraining a substance is delivered at a driving pressure sufficient to cause the gas to flow around the posterior margin of the nasal septum of the subject and out of the other nostril of the subject.

9. A combination of the device of claim 1 and a substance to be delivered.

10. The combination of claim 9, wherein the substance comprises particles principally in the range of about 1 to 10 .mu.m.

11. A combination of the device of claim 1 and a separate outlet unit, wherein the separate outlet unit comprises a nosepiece shaped and sized for insertion into the other nostril of the subject, and a flow resistor located downstream of the other nostril, wherein the separate outlet unit is configured to cause the generation of a dynamic positive pressure in the nasal airway.

12. The combination of claim 11, wherein the separate outlet unit further comprises an indicator for signaling when a predetermined positive pressure has been reached upstream of the indicator in the nasal airway of the subject.

13. The combination of claim 11, wherein the flow resistor is adjustable to allow for adjustment of the level of resistance and thereby provide control of the dynamic pressure in the nasal airway of the subject.

14. The device of claim 1, wherein the substance comprises a liquid.

15. The device of claim 1, wherein the substance comprises a powder.

16. The device of claim 1, wherein the exhalation air flow has a flow rate of at least 15 liters per minute.

17. The device of claim 1, wherein the exhalation air flow has a flow rate of at least 20 liters per minute.

18. The device of claim 1, wherein the exhalation air flow has a flow rate of about 10 to 20 liters per minute.

19. The device of claim 1, wherein the exhalation air flow has a delivery time of about 2 to 5 seconds.

20. The device of claim 1, further configured to cause the generation of a dynamic positive pressure of at least 5 cm H.sub.20 in the nasal airway.

21. The device of claim 1, further configured to cause the generation of a dynamic positive pressure of at least 50 cm H.sub.20 in the nasal airway.

22. The device of claim 1, further configured to cause the generation of a dynamic positive pressure of at least 100 cm H.sub.20 in the nasal airway.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc